Ardent Health, Inc. — Form 8-K
Filed November 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Ardent Health (market cap ~$324M) executed a secondary offering on 11/19/2026: selling shareholders EGI-AM Investments, L.L.C. and ALH Holdings, LLC sold 8,000,000 shares at $13.70/share ($109.6M gross), with underwriters J.P. Morgan and Barclays as co-leads. Company repurchases 1,500,000 shares from underwriters at same price (~$20.6M). Underwriters hold option for 1,200,000 additional shares. No proceeds to Ardent; pure secondary (selling shareholders liquidity).
Why this rating
Secondary offering dilutes existing holders ~2.5% (8M new shares), but no cash to company. Repurchase offsets dilution partially. Routine capital market event relative to company size.
See more from November 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.